³Ô¹ÏÍøÕ¾

Latest

Latest antibody News

  • Latest antibody news stories and updates. What is happening today? All recent antibody news and developments. Live coverage and timeline of antibody. All you need to know about antibody.
NSW To Rollout New Free RSV Prevention Program In 2025
Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences
ADx NeuroSciences and Alamar Biosciences Announce Partnership to Provide Customized Blood-Based Biomarker Assay Solutions to Accelerate Biopharma Clinical Development
Remote-controlled Car For Cancer Immunotherapy
Intra-molecular distances in biomolecules measured optically with Ångström precision 
Clinical trial of asthma injection that aims to reduce airway inflammation
Types of data requested to inform December 2024 COVID-19 vaccine antigen composition deliberations
GPs commend Victorian Government for taking action on RSV
Protecting Victorian Newborns And Infants Next Winter
Immune cells key in blood vessel damage, neurodegeneration
Galderma Reaffirms Its Leadership in Dermatology With Extensive Presence at EADV 2024
Telix’s Phase 3 ZIRCON trial for kidney cancer imaging published in The Lancet Oncology
COVID, flu and RSV: Know the vaccines for these three common respiratory viruses
Immutep announces first participant dosed in Phase 1 study of IMP761
CSL Reports Strong Profit Growth For Full Year 2024
Understanding malaria vaccines: key to improving vaccines for children
SOTIO Enters into Multi-Target Antibody Agreement with Biocytogen to Expand ADC Pipeline
WHO prequalifies the first self-test for hepatitis C virus
Florey biotech spin-out secures seed investment from Curie.Bio
Miles Doing What Matters: Free RSV immunisation success for Queensland newborns
JJP Biologics Announces Positive Decision to Execute a First-in-Human Clinical Trial of Anti-Inflammatory mAb JJP-1212 (anti-CD89)
Telix completes proof-of-concept study of TLX592 in prostate cancer
Immutep appoints research institute to conduct first-in-human study of IMP761
Free RSV immunisation program for Queensland infants and young children
Pradeepa Pushparaj is awarded Sven Gard´s scholarship 2024
2024 RSV Infant Immunisation Program
Two datopotamab deruxtecan applications validated in the EU for patients with advanced nonsquamous non-small cell lung cancer or HR-positive, HER2-negative breast cancer
Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated advanced nonsquamous non-small cell lung cancer
Full Year and Q4 2023 results
Enhertu granted Priority Review in the US for patients with metastatic HER2-positive solid tumours
Why you should feed both cold and fever
World-first breakthrough in malaria treatment
La Trobe University and AdAlta collaboration delivers world-first breakthrough in malaria treatment
FDA grants fast-track designation for EnGeneIC’s pancreatic cancer candidate
Statement on the antigen composition of COVID-19 vaccines
Being overweight hampers immune response to SARS-CoV-2
AstraZeneca advances scientific leadership in haematology at ASH 2023
Social network of proteins
Telix says first patient dosed in ProstACT study of prostate cancer candidate
9M and Q3 2023 results
Imugene announces phase 1 clinical trial opens with onCARlytics CD19 virus technology
Arovella Therapeutics licences monoclonal antibody for cell therapy development
New treatment offers hope for advanced liver cancer
Datopotamab deruxtecan demonstrated statistically significant and clinically meaningful progression-free survival benefit in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01…
Imugene secures new patent in Japan for PD1-Vaxx clinical drug candidate
Enhertu demonstrated strong and durable tumour responses in previously treated HER2-mutant advanced lung cancer in DESTINY-Lung02 Phase II trial
Advanced Technology Reveals Intricate Details of Zinc Transportation in Cells
Does picking your nose really increase your risk of COVID?

© 2024 - ³Ô¹ÏÍøÕ¾